The single evaluation indictor of new drug quality hinders the market and customers' cognition of new drug quality, which is not conducive to the rapid launch of new drugs. Based on the market, this research establishes a comprehensive evaluation indictor system of new drug quality from the perspective of customer demand. To improve the quality of new drugs, as soon as possible to provide scientific basis for the market.